Resource
Corporate Compliance Supplier Code of Conduct
This Supplier Code of Conduct (the “Code”) describes the ethical principles and compliance commitments required of Suppliers when doing business with…
Featured Insights
Ask the Experts: Understanding Juvenile Idiopathic Arthritis
In light of JIA Awareness Month, its treatments, its stigma, and more, we spoke with Dr. Johnny Peppers, Executive Director of Drug Development for…
PRA Teams with Microsoft to Enhance COVID-19 Monitoring
Over the past several months, participants in PRA Health Sciences’ Health Harmony COVID-19 Monitoring Program have had vital information about…
All Insights
Resource
Publication
Three Necessary Steps When Designing your New World Protocol
This article explores the design of a protocol that includes decentralized components. After a clinical-trial protocol has been developed, adding…
Blog
Navigating Global Regulatory CMC Processes During Public Health Crises
Chemistry, manufacturing, and controls (CMC) regulations are a critical part of the drug development path and the ongoing production and distribution…
Fact Sheet
Biotech Solutions Fact Sheet
Biotech is in our DNA. PRA has recognized the importance of emerging biopharma since our humble beginnings, when we first started partnering with…
Newsletter
RARE DISEASES NEWSLETTER Volume 17, July 2020
Welcome to the seventeenth edition of the rare disease newsletter. A few months has changed the world of clinical research into a very different…
Newsletter
Industry Watch
This week we bring you news of a gene therapy with the potential to change lives for children with Duchenne muscular dystrophy, having experienced…
Fact Sheet
The Center for Immuno-oncology, Cellular, and Gene Therapy
The Center for Immuno-oncology, Cellular, and Gene Therapy leverages our comprehensive experience and cross-functional experts to build…
Blog
Ask the Experts: What do We Need to Know about Hepatitis and its Awareness?
Hepatitis is an inflammatory disease that affects the liver. Certain types can lead to liver cancer or even death. According to the World Health…
Case Study
Collaboration in Neonatal Study Addresses and Resolves Multi-Stage Difficulties
PRA’s project team turned around a challenging neonatal seizure study to enable successful recruitment. The relationships between the sponsor and the…
Blog
A Caregiver’s Experience with Glioblastoma
Glioblastoma (GBM) is one of the most complex, deadly, treatment-resistant cancers that accounts for 48% of all primary malignant brain tumors. In…